8JD.F VALBIOTIS S.A. EO -10

Consumer Defensive Biotechnology Frankfurt Exchange
0.5730 EUR
Close of Nov 11, 2026
0.4945 1.29
Market cap
EUR 20.3M
P/E
-
P/B
1.68x
ROE
-135.3%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 8JD.F undervalued?

Graham number

The Graham number of VALBIOTIS S.A. EO -10 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

VALBIOTIS S.A. EO -10 fundamental analysis

No fundamental analysis for VALBIOTIS S.A. EO -10 yet.

VALBIOTIS S.A. EO -10 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About VALBIOTIS S.A. EO -10

Valbiotis SA engages in the research and development of dietary supplements to prevent metabolic and cardiovascular diseases in France and Asia. The company offers supplements for immunity and vitality, health and wellbeing, metabolic and cardiovascular health, and beauty and physical comfort. It also develops TOTUM-63 for the reduction of fasting blood glucose and treatment of type 2 diabetes; TOTUM-854, which is in Phase II/III clinical trials for reducing systolic blood p…

Full company profile